Theriva Biologics Inc. (TOVX) financials · $12.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Theriva Biologics Inc. (TOVX) $12.4M cap.
| Line | Q1 2026 | FY2025 |
|---|---|---|
| Revenue | $300.0K | N/A |
| Operating Income | -$2.13M | N/A |
| Net Income | -$2.04M | -$4.36M |
| EPS (Diluted) | -$0.05 | -$0.45 |
| Line | Q1 2026 | FY2025 |
|---|---|---|
| Total Assets | $38.2M | $38.2M |
| Current Assets | $16.8M | $17.5M |
| Cash & Equivalents | $14.4M | $13.1M |
| PP&E | $194.0K | $222.0K |
| Total Liabilities | $22.8M | $22.9M |
| Current Liabilities | $10.3M | $10.0M |
| Long-term Debt | N/A | $1.67M |
| Total Debt | N/A | $1.67M† |
| Shareholders' Equity | $15.4M | $15.4M |
| Retained Earnings | -$360.8M | -$358.7M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Cash Flow | -$16.9M | -$19.0M |
| CapEx | N/A | $202.0K |
| Investing Cash Flow | -$1.00K | -$202.0K |
| Financing Cash Flow | $5.50M | $625.0K |
| Net Change in Cash | N/A | -$18.6M |
| Free Cash Flow | N/A | -$19.2M |
FAQ
What is TOVX P/E and revenue?
Theriva Biologics Inc. (TOVX) $12.4M cap.
What is TOVX revenue?
Theriva Biologics Inc. last cached revenue is $300.0K (Q1 2026).
Is TOVX profitable?
Theriva Biologics Inc. last cached net income is -$2.04M (Q1 2026).
What are TOVX total assets?
Theriva Biologics Inc. last cached total assets are $38.2M (Q1 2026).
What is TOVX free cash flow?
No cached cash-flow row for TOVX yet.
Not investment advice. Cached statements, not a live tape.